Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
TruBridge, Inc. NASDAQ:TBRG, a healthcare technology company whose stock has delivered a remarkable 51% return over the past year, saw its General Manager Patient Care, Harse David, sell 1,744 shares of common stock on March 14, 2025, at a price of $27.40, for a total transaction value of $47,785. According to InvestingPro analysis, the stock appears undervalued despite its strong performance.
Following the transaction, Harse David directly owns 18,058 shares of TruBridge, Inc. While the company currently shows negative earnings, InvestingPro data reveals analysts expect profitability this year, with multiple analysts revising earnings estimates upward. Get deeper insights into insider trading patterns and 7+ additional ProTips with an InvestingPro subscription.
In other recent news, Cantor Fitzgerald has reiterated its Overweight rating on TruBridge Inc, maintaining a price target of $29.00. The firm expressed optimism about the company’s sales pipeline, which is reportedly on track for 2025. Analysts at Cantor Fitzgerald also noted several positive signals extending into 2026. These developments suggest a favorable outlook for TruBridge’s future performance, according to the research firm. Investors may find this information pertinent as it reflects confidence from a notable analyst firm. This reiteration of the stock rating highlights the continued positive sentiment surrounding TruBridge’s potential growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.